DOCSLIB.ORG

Common Errors in Statistics (And How to Avoid Them) Common Errors in Statistics (And How to Avoid Them)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Common Errors in Statistics (And How to Avoid Them) Common Errors in Statistics (And How to Avoid Them) COMMON ERRORS IN STATISTICS (AND HOW TO AVOID THEM) COMMON ERRORS IN STATISTICS (AND HOW TO AVOID THEM) Fourth Edition Phillip I. Good Statcourse.com Huntington Beach, CA James W. Hardin Dept. of Epidemiology & Biostatistics Institute for Families in Society University of South Carolina Columbia, SC A JOHN WILEY & SONS, INC., PUBLICATION Cover photo: Gary Carlsen, DDS Copyright © 2012 by John Wiley & Sons, Inc. All rights reserved. Published by John Wiley & Sons, Inc., Hoboken, New Jersey Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permissions. Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifi cally disclaim any implied warranties of merchantability or fi tness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Neither the publisher nor author shall be liable for any loss of profi t or any other commercial damages, including but not limited to special, incidental, consequential, or other damages. For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002. Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic formats. For more information about Wiley products, visit our web site at www.wiley.com. Library of Congress Cataloging-in-Publication Data: Good, Phillip I. Common errors in statistics (and how to avoid them) / Phillip I. Good, Statcourse.com, Huntington Beach, CA, James W. Hardin, Dept. of Epidemiology & Biostatistics, University of South Carolina, Columbia, SC. – Fourth edition. pages cm Includes bibliographical references and index. ISBN 978-1-118-29439-0 (pbk.) 1. Statistics. I. Hardin, James W. (James William) II. Title. QA276.G586 2012 519.5–dc23 2012005888 Printed in the United States of America 10 9 8 7 6 5 4 3 2 1 Contents Preface xi PART I FOUNDATIONS 1 1. Sources of Error 3 Prescription 4 Fundamental Concepts 5 Surveys and Long-Term Studies 9 Ad-Hoc, Post-Hoc Hypotheses 9 To Learn More 13 2. Hypotheses: The Why of Your Research 15 Prescription 15 What Is a Hypothesis? 16 How Precise Must a Hypothesis Be? 17 Found Data 18 Null or Nil Hypothesis 19 Neyman–Pearson Theory 20 Deduction and Induction 25 Losses 26 Decisions 27 To Learn More 28 3. Collecting Data 31 Preparation 31 Response Variables 32 Determining Sample Size 37 Fundamental Assumptions 46 Experimental Design 47 CONTENTS v Four Guidelines 49 Are Experiments Really Necessary? 53 To Learn More 54 PART II STATISTICAL ANALYSIS 57 4. Data Quality Assessment 59 Objectives 60 Review the Sampling Design 60 Data Review 62 To Learn More 63 5. Estimation 65 Prevention 65 Desirable and Not-So-Desirable Estimators 68 Interval Estimates 72 Improved Results 77 Summary 78 To Learn More 78 6. Testing Hypotheses: Choosing a Test Statistic 79 First Steps 80 Test Assumptions 82 Binomial Trials 84 Categorical Data 85 Time-To-Event Data (Survival Analysis) 86 Comparing the Means of Two Sets of Measurements 90 Do Not Let Your Software Do Your Thinking For You 99 Comparing Variances 100 Comparing the Means of K Samples 105 Higher-Order Experimental Designs 108 Inferior Tests 113 Multiple Tests 114 Before You Draw Conclusions 115 Induction 116 Summary 117 To Learn More 117 7. Strengths and Limitations of Some Miscellaneous Statistical Procedures 119 Nonrandom Samples 119 Modern Statistical Methods 120 Bootstrap 121 vi CONTENTS Bayesian Methodology 123 Meta-Analysis 131 Permutation Tests 135 To Learn More 137 8. Reporting Your Results 139 Fundamentals 139 Descriptive Statistics 144 Ordinal Data 149 Tables 149 Standard Error 151 p-Values 155 Confi dence Intervals 156 Recognizing and Reporting Biases 158 Reporting Power 160 Drawing Conclusions 160 Publishing Statistical Theory 162 A Slippery Slope 162 Summary 163 To Learn More 163 9. Interpreting Reports 165 With a Grain of Salt 165 The Authors 166 Cost–Benefi t Analysis 167 The Samples 167 Aggregating Data 168 Experimental Design 168 Descriptive Statistics 169 The Analysis 169 Correlation and Regression 171 Graphics 171 Conclusions 172 Rates and Percentages 174 Interpreting Computer Printouts 175 Summary 178 To Learn More 178 10. Graphics 181 Is a Graph Really Necessary? 182 KISS 182 The Soccer Data 182 Five Rules for Avoiding Bad Graphics 183 CONTENTS vii One Rule for Correct Usage of Three-Dimensional Graphics 194 The Misunderstood and Maligned Pie Chart 196 Two Rules for Effective Display of Subgroup Information 198 Two Rules for Text Elements in Graphics 201 Multidimensional Displays 203 Choosing Effective Display Elements 209 Oral Presentations 209 Summary 210 To Learn More 211 PART III BUILDING A MODEL 213 11. Univariate Regression 215 Model Selection 215 Stratifi cation 222 Further Considerations 226 Summary 233 To Learn More 234 12. Alternate Methods of Regression 237 Linear Versus Nonlinear Regression 238 Least-Absolute-Deviation Regression 238 Quantile Regression 243 Survival Analysis 245 The Ecological Fallacy 246 Nonsense Regression 248 Reporting the Results 248 Summary 248 To Learn More 249 13. Multivariable Regression 251 Caveats 251 Dynamic Models 256 Factor Analysis 256 Reporting Your Results 258 A Conjecture 260 Decision Trees 261 Building a Successful Model 264 To Learn More 265 viii CONTENTS 14. Modeling Counts and Correlated Data 267 Counts 268 Binomial Outcomes 268 Common Sources of Error 269 Panel Data 270 Fixed- and Random-Effects Models 270 Population-Averaged Generalized Estimating Equation Models (GEEs) 271 Subject-Specifi c or Population-Averaged? 272 Variance Estimation 272 Quick Reference for Popular Panel Estimators 273 To Learn More 275 15. Validation 277 Objectives 277 Methods of Validation 278 Measures of Predictive Success 283 To Learn More 285 Glossary 287 Bibliography 291 Author Index 319 Subject Index 329 CONTENTS ix Preface ONE OF THE VERY FIRST TIMES DR. GOOD served as a statistical consultant, he was asked to analyze the occurrence rate of leukemia cases in Hiroshima, Japan following World War II. On August 7, 1945 this city was the target site of the fi rst atomic bomb dropped by the United States. Was the high incidence of leukemia cases among survivors the result of exposure to radiation from the atomic bomb? Was there a relationship between the number of leukemia cases and the number of survivors at certain distances from the atomic bomb ’ s epicenter? To assist in the analysis, Dr. Good had an electric (not an electronic) calculator, reams of paper on which to write down intermediate results, and a prepublication copy of Scheffe ’ s Analysis of Variance . The work took several months and the results were somewhat inconclusive, mainly because he could never seem to get the same answer twice — a consequence of errors in transcription rather than the absence of any actual relationship between radiation and leukemia. Today, of course, we have high - speed computers and prepackaged statistical routines to perform the necessary calculations. Yet, statistical software will no more make one a statistician than a scalpel will turn one into a neurosurgeon. Allowing these tools to do our thinking is a sure recipe for disaster. Pressed by management or the need for funding, too many research workers have no choice but to go forward with data analysis despite having insuffi cient statistical training. Alas, though a semester or two of undergraduate statistics may develop familiarity with the names of some statistical methods, it is not enough to be aware of all the circumstances under which these methods may be applicable. PREFACE xi The purpose of the present text is to provide a mathematically rigorous but readily understandable foundation for statistical procedures. Here are such basic concepts in statistics as null and alternative hypotheses, p - value, signifi cance level, and power. Assisted by reprints from the statistical literature, we reexamine sample selection, linear regression, the analysis of variance, maximum likelihood, Bayes ’ Theorem, meta - analysis and the bootstrap. New to this edition are sections on fraud and on the potential sources of error to be found in epidemiological and case - control studies. Examples of good and bad statistical methodology are drawn from agronomy, astronomy, bacteriology, chemistry, criminology, data mining, epidemiology, hydrology, immunology, law, medical devices, medicine, neurology, observational studies, oncology, pricing, quality control, seismology, sociology, time series, and toxicology. More good news: Dr. Good ’ s articles on women sports have appeared in the San Francisco Examiner , Sports Now , and Volleyball Monthly ; 22 short stories of his are in print; and you can fi nd his 21 novels on Amazon and zanybooks.com. So, if you can read the sports page, you ’ ll fi nd this text easy to read and to follow.
Load more

Recommended publications
  • What Statistics Can and Can't Tell Us About Ourselves | the New Yorker
    What Statistics Can and Canʼt Tell Us About Ourselves | The New Yorker 2019-09-04, 1005 Books September 9, 2019 Issue What Statistics Can and Can’t Tell Us About Ourselves In the era of Big Data, we’ve come to believe that, with enough information, human behavior is predictable. But number crunching can lead us perilously wrong. By Hannah Fry September 2, 2019 https://www.newyorker.com/magazine/2019/09/09/what-statistics…3&utm_medium=email&utm_term=0_c9dfd39373-f791742ba3-42227231 Page 1 of 15 What Statistics Can and Canʼt Tell Us About Ourselves | The New Yorker 2019-09-04, 1005 Making individual predictions from collective characteristics is a risky business. Illustration by Ben Wiseman 0"00 / 23"27 Audio: Listen to this article. To hear more, download Audm for iPhone or Android. arold Eddleston, a seventy-seven-year-old from Greater Manchester, H was still reeling from a cancer diagnosis he had been given that week https://www.newyorker.com/magazine/2019/09/09/what-statistics…3&utm_medium=email&utm_term=0_c9dfd39373-f791742ba3-42227231 Page 2 of 15 What Statistics Can and Canʼt Tell Us About Ourselves | The New Yorker 2019-09-04, 1005 when, on a Saturday morning in February, 1998, he received the worst possible news. He would have to face the future alone: his beloved wife had died unexpectedly, from a heart attack. Eddleston’s daughter, concerned for his health, called their family doctor, a well-respected local man named Harold Shipman. He came to the house, sat with her father, held his hand, and spoke to him tenderly.
    [Show full text]
  • Note for the Record: Consultation on Clinical Trial Design for Ebola Virus Disease (EVD)
    Note for the record: Consultation on Clinical Trial Design for Ebola Virus Disease (EVD) A group of independent scientific experts was convened by the WHO for the purpose of evaluating a proposed clinical trial design for investigational therapeutics for Ebola virus disease (EVD) during the current outbreak, 26 May 2018 Experts Sir Michael Jacobs (Chair), Dr Rick Bright, Dr Marco Cavaleri, Dr Edward Cox, Dr Natalie Dean, Dr William Fischer, Dr Thomas Fleming, Dr Elizabeth Higgs, Dr Peter Horby, Dr Philip Krause, Dr Trudie Lang, Dr Denis Malvy, Sir Richard Peto, Dr Peter Smith, Dr Marianne Van der Sande, Dr Robert Walker, Dr David Wohl, Dr Alan Young. There are many pathogens for which there is no proven specific treatment. For some pathogens, there are treatments that have shown promising safety and activity in the laboratory and in relevant animal models but have not yet been evaluated fully for safety and efficacy in humans. In the context of an outbreak characterized by high mortality rates, the Monitored Emergency Use of Unregistered Interventions (MEURI)1 framework is a means to provide access to promising but unproven investigational therapies, but is not a means to evaluate reliably whether these compounds are actually beneficial to patients or not. In light of the current Ebola Zaire DRC outbreak with a high case fatality rate, the WHO convened an independent expert panel to evaluate investigational therapeutics for MEURI use2, and that panel affirmed the importance of moving to appropriate clinical trials as soon as possible. Against this background, a clinical trial design has been proposed with a view to generating reliable evidence about safety and efficacy.
    [Show full text]
  • Graphical Methods for Detecting Bias in Meta-Analysis
    See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/13513488 Graphical methods for detecting bias in meta-analysis Article in Family medicine · October 1998 Source: PubMed CITATIONS READS 26 702 1 author: Robert Ferrer University of Texas Health Science Center at San Antonio 79 PUBLICATIONS 2,097 CITATIONS SEE PROFILE Some of the authors of this publication are also working on these related projects: Small Troubles, Adaptive Responses View project All content following this page was uploaded by Robert Ferrer on 06 January 2014. The user has requested enhancement of the downloaded file. Vol. 30, No. 8 579 Research Series Graphical Methods for Detecting Bias in Meta-analysis Robert L. Ferrer, MD, MPH The trustworthiness of meta-analysis, a set of techniques used to quantitatively combine results from different studies, has recently been questioned. Problems with meta-analysis stem from bias in selecting studies to include in a meta-analysis and from combining study results when it is inappro- priate to do so. Simple graphical techniques address these problems but are infrequently applied. Funnel plots display the relationship of effect size versus sample size and help determine whether there is likely to have been selection bias in including studies in the meta-analysis. The L’Abbé plot displays the outcomes in both the treatment and control groups of included studies and helps to decide whether the studies are too heterogeneous to appropriately combine into a single measure of effect. (Fam Med 1998;30(8):579-83.) Our faith in the answers provided by scientific in- multiple studies to see the patterns that clarify a line quiry rests on our confidence that its methods are of scientific inquiry.
    [Show full text]
  • Sir Richard Doll, Epidemiologist – a Personal Reminiscence with a Selected Bibliography
    British Journal of Cancer (2005) 93, 963 – 966 & 2005 Cancer Research UK All rights reserved 0007 – 0920/05 $30.00 www.bjcancer.com Obituary Sir Richard Doll, epidemiologist – a personal reminiscence with a selected bibliography The death of Richard Doll on 24 July 2005 at the age of 92 after a short illness ended an extraordinarily productive life in science for which he received widespread recognition, including Fellowship of The Royal Society (1966), Knighthood (1971), Companionship of Honour (1996), and many honorary degrees and prizes. He is unique, however, in having seen both universal acceptance of his work demonstrating smoking as the main cause of the most common fatal cancer in the world and the relative success of strategies to reduce the prevalence of the habit. In 1950, 80% of the men in Britain smoked but this has now declined to less than 30%. Richard Doll qualified in medicine at St Thomas’ Hospital in 1937, but his epidemiological career began after service in the Second World War when he worked with Francis Avery Jones at the Central Middlesex Hospital on occupational factors in the aetiology of peptic ulceration. The completeness of Doll’s tracing of previously surveyed men so impressed Tony Bradford Hill that he offered him a post in the MRC Statistical Research Unit to investigate the causes of lung cancer. For the representations of Percy Stocks (Chief Medical Officer to the Registrar General) and Sir Ernest Kennaway had prevailed against the then commonly held view that the marked rise in lung cancer deaths in Britain since 1900 was due only to improved diagnosis.
    [Show full text]
  • Science for Judges Ii
    BERGERINTRO.DOC 4/23/2004 12:32 PM SCIENCE FOR JUDGES II INTRODUCTION Margaret A. Berger* This issue of the Journal of Law and Policy contains a second installment of articles about science-related questions that arise in the litigation context. As previously explained, these essays are expanded and edited versions of presentations made to federal and state judges at programs funded by the Common Benefit Trust established in the Silicone Breast Implant Products Liability Litigation.1 These conferences are held at Brooklyn Law School under the auspices of its Center for Health Law and Policy, in collaboration with the Federal Judicial Center, the National Center for State Courts, and the National Academies of Science=s Panel on Science, Technology and Law. Science for Judges II focused on two principal topics: (1) the practice of epidemiology and its role in judicial proceedings; and (2) the production of science through the regulatory process of administrative agencies. Epidemiology has played a significant role in toxic tort actions in proving causation, often the most crucial issue in dispute. A failure to prove causation means a victory for the defense. Many courts consider epidemiologic evidence the “gold standard” of proof, and some judges go so far as to hold that a plaintiff cannot prevail in proving causation in the absence of confirmatory epidemiologic studies.2 The three papers on epidemiology by * Suzanne J. and Norman Miles Professor of Law, Brooklyn Law School. Professor Berger is the Director of the Science for Judges Program. 1 See Margaret A. Berger, Introduction, Science for Judges, 12 J.
    [Show full text]
  • Whoseжlegacyжwillжreadersж Celebrateжthisжyear?
    BMJ GROUP AWARDS •ЖReviewЖtheЖshortlistsЖforЖallЖcategoriesЖatЖhttp://bit.ly/aUWoE5 Sir George Alleyne •ЖListenЖtoЖtheЖawardsЖlaunchЖpodcastЖatЖbmj.com/podcasts A highly respected figure in global health, George Alleyne has played LIFETIME ACHIEVEMENT AWARD a large part in tackling HIV and non-communicable disease and WhoseЖlegacyЖwillЖreadersЖ is an energetic promoter of health equality across the world. Currently the chancellor of the University celebrateЖthisЖyear? of the West Indies, Sir George is also the former director of the Pan Annabel FerrimanЖintroducesЖthisЖyear’sЖawardЖandЖ American Health Organization. Adrian O’DowdЖrevealsЖtheЖshortlistedЖcandidates Born in Barbados, he graduated in medicine from the University When Belgian senator Marleen Temmerman called on women in Belgium of the West Indies in 1957 and to refuse to have sex with their partners until the country’s politicians continued his postgraduate ended eight months of wrangling and formed a government, few people studies in the United Kingdom and effect on national economies. in the UK had heard of her. But readers of the BMJ were in the know and the United States. During more Sir George has served on various unsurprised. than a decade of original research, committees including the For Professor Temmerman, an obstetrician and gynaecologist, had he produced 144 publications in scientific and technical advisory won the BMJ Group’s Lifetime Achievement Award last April. In that case, scientific journals, which qualified committee of the World Health it was not for suggesting a “crossed leg strike” to end political deadlock him at just 40 years of age to be Organization Tropical Research (a solution advocated by the women of Greece in Aristophanes’ play appointed professor of medicine Programme and the Institute of Lysistrata) but for her services to women’s health in Belgium and Kenya.
    [Show full text]
  • Methodological Challenges Associated with Meta-Analyses in Health Care and Behavioral Health Research
    o title: Methodological Challenges Associated with Meta Analyses in Health Care and Behavioral Health Research o date: May 14, 2012 Methodologicalo author: Challenges Associated with Judith A. Shinogle, PhD, MSc. Meta-AnalysesSenior Research Scientist in Health , Maryland InstituteCare for and Policy Analysis Behavioraland Research Health Research University of Maryland, Baltimore County 1000 Hilltop Circle Baltimore, Maryland 21250 http://www.umbc.edu/mipar/shinogle.php Judith A. Shinogle, PhD, MSc Senior Research Scientist Maryland Institute for Policy Analysis and Research University of Maryland, Baltimore County 1000 Hilltop Circle Baltimore, Maryland 21250 http://www.umbc.edu/mipar/shinogle.php Please see http://www.umbc.edu/mipar/shinogle.php for information about the Judith A. Shinogle Memorial Fund, Baltimore, MD, and the AKC Canine Health Foundation (www.akcchf.org), Raleigh, NC. Inquiries may also be directed to Sara Radcliffe, Executive Vice President for Health, Biotechnology Industry Organization, www.bio.org, 202-962-9200. May 14, 2012 Methodological Challenges Associated with Meta-Analyses in Health Care and Behavioral Health Research Judith A. Shinogle, PhD, MSc I. Executive Summary Meta-analysis is used to inform a wide array of questions ranging from pharmaceutical safety to the relative effectiveness of different medical interventions. Meta-analysis also can be used to generate new hypotheses and reflect on the nature and possible causes of heterogeneity between studies. The wide range of applications has led to an increase in use of meta-analysis. When skillfully conducted, meta-analysis is one way researchers can combine and evaluate different bodies of research to determine the answers to research questions. However, as use of meta-analysis grows, it is imperative that the proper methods are used in order to draw meaningful conclusions from these analyses.
    [Show full text]
  • A Cancer Control Interview With: Sir Richard Peto
    CANCER CONTROL PLANNING A CANCER CONTROL INTERVIEW WITH: SIR RICHARD PETO Sir Richard Peto is Professor of Medical Statistics & Epidemiology at the University of Oxford, United Kingdom. In 1975, he set up the Clincial Trial Service Unit in the Medical Sciences Division of Oxford University, of which he and Rory Collins are now co-directors. Professor Peto's work has included studies of the causes of cancer in general, and of the effects of smoking in particular, and the establishment of large-scale randomised trials of the treatment of heart disease, stroke, cancer and a variety of other diseases. He has been instrumental in introducing combined "meta-analyses" of results from related trials that achieve uniquely reliable assessment of treatment effects. He was elected a Fellow of the Royal Society of London in 1989, and was knighted (for services to epidemiology and to cancer prevention) in 1999. Cancer Control: How should the global target of a 25% reduction country would die before they were 70; now it is 18%. in premature mortality from non-communicable diseases (NCDs) by 2025 be interpreted? Cancer Control: NCD advocates place great emphasis on the Sir Richard Peto: I would define “premature death” as death relative burden of non-communicable diseases compared with during the middle age range of 35 to 69 years. It’s not that communicable diseases. Are they right to do so? deaths after 70 don’t matter – I’m after 70 myself and I’m Sir Richard Peto: I don’t like these things that say “More still enjoying life – but if you are going to do things to reduce people die from NCDs than from communicable disease and NCDs then it is going to be to reduce NCD mortality in your therefore NCDs are more important”.
    [Show full text]
  • A Kernel Log-Rank Test of Independence for Right-Censored Data
    A kernel log-rank test of independence for right-censored data Tamara Fern´andez∗ Arthur Gretton University College London University College London [email protected] [email protected] David Rindt Dino Sejdinovic University of Oxford University of Oxford [email protected] [email protected] November 18, 2020 Abstract We introduce a general non-parametric independence test between right-censored survival times and covariates, which may be multivariate. Our test statistic has a dual interpretation, first in terms of the supremum of a potentially infinite collection of weight-indexed log-rank tests, with weight functions belonging to a reproducing kernel Hilbert space (RKHS) of functions; and second, as the norm of the difference of embeddings of certain finite measures into the RKHS, similar to the Hilbert-Schmidt Independence Criterion (HSIC) test-statistic. We study the asymptotic properties of the test, finding sufficient conditions to ensure our test correctly rejects the null hypothesis under any alternative. The test statistic can be computed straightforwardly, and the rejection threshold is obtained via an asymptotically consistent Wild Bootstrap procedure. Extensive simulations demonstrate that our testing procedure generally performs better than competing approaches in detecting complex non-linear dependence. 1 Introduction Right-censored data appear in survival analysis and reliability theory, where the time-to-event variable one is interested in modelling may not be observed fully, but only in terms of a lower bound. This is a common occurrence in clinical trials as, usually, the follow-up is restricted to the duration of the study, or patients may decide to withdraw from the study.
    [Show full text]
  • STATISTICAL SCIENCE Volume 31, Number 4 November 2016
    STATISTICAL SCIENCE Volume 31, Number 4 November 2016 ApproximateModelsandRobustDecisions..................James Watson and Chris Holmes 465 ModelUncertaintyFirst,NotAfterwards....................Ingrid Glad and Nils Lid Hjort 490 ContextualityofMisspecificationandData-DependentLosses..............Peter Grünwald 495 SelectionofKLNeighbourhoodinRobustBayesianInference..........Natalia A. Bochkina 499 IssuesinRobustnessAnalysis.............................................Michael Goldstein 503 Nonparametric Bayesian Clay for Robust Decision Bricks ..................................................Christian P. Robert and Judith Rousseau 506 Ambiguity Aversion and Model Misspecification: An Economic Perspective ................................................Lars Peter Hansen and Massimo Marinacci 511 Rejoinder: Approximate Models and Robust Decisions. .James Watson and Chris Holmes 516 Filtering and Tracking Survival Propensity (Reconsidering the Foundations of Reliability) .......................................................................Nozer D. Singpurwalla 521 On Software and System Reliability Growth and Testing. ..............FrankP.A.Coolen 541 HowAboutWearingTwoHats,FirstPopper’sandthendeFinetti’s?..............Elja Arjas 545 WhatDoes“Propensity”Add?...................................................Jane Hutton 549 Reconciling the Subjective and Objective Aspects of Probability ...............Glenn Shafer 552 Rejoinder:ConcertUnlikely,“Jugalbandi”Perhaps..................Nozer D. Singpurwalla 555 ChaosCommunication:ACaseofStatisticalEngineering...............Anthony
    [Show full text]
  • Warwick.Ac.Uk/Lib-Publications
    A Thesis Submitted for the Degree of PhD at the University of Warwick Permanent WRAP URL: http://wrap.warwick.ac.uk/87969 Copyright and reuse: This thesis is made available online and is protected by original copyright. Please scroll down to view the document itself. Please refer to the repository record for this item for information to help you to cite it. Our policy information is available from the repository home page. For more information, please contact the WRAP Team at: [email protected] warwick.ac.uk/lib-publications An exploration of the construct of psychopathy, its measurement and neuropsychological correlates Gary Burgess This thesis is submitted in partial fulfilment of the requirements for the degree of Doctorate in Clinical Psychology Coventry University, Faculty of Health and Life Sciences University of Warwick, Department of Psychology May 2016 i Contents v Chapter 1; Literature Review 1 1.0 Abstract ........................................................................................................................................................ 2 Aim 2 Method 2 Findings 2 Conclusion 3 1.1 Introduction............................................................................................................................................... 4 1.1.2 Structure and Function of the Brain in Psychopathy 5 1.1. 3 Neuropsychological and Neurocognitive Approach 9 1.1.4 Subtypes 10 1.1.5 Factor structure models of psychopathy 11 1.1.6 Aims of Present Review 15 1.2 Method ......................................................................................................................................................
    [Show full text]
  • Asymptotically Efficient Rank Invariant Test Procedures Author(S): Richard Peto and Julian Peto Source: Journal of the Royal Statistical Society
    Asymptotically Efficient Rank Invariant Test Procedures Author(s): Richard Peto and Julian Peto Source: Journal of the Royal Statistical Society. Series A (General), Vol. 135, No. 2 (1972), pp. 185-207 Published by: Wiley for the Royal Statistical Society Stable URL: http://www.jstor.org/stable/2344317 Accessed: 21-04-2017 17:23 UTC JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact [email protected]. Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at http://about.jstor.org/terms Royal Statistical Society, Wiley are collaborating with JSTOR to digitize, preserve and extend access to Journal of the Royal Statistical Society. Series A (General) This content downloaded from 171.65.37.237 on Fri, 21 Apr 2017 17:23:40 UTC All use subject to http://about.jstor.org/terms J. R. Statist. Soc. A, 185 (1972), 135, Part 2, p. 185 Asymptotically Efficient Rank Invariant Test Procedures By RICHARD PETO AND JULIAN PETO Radcliffe Infirmary, Institute of Psychiatry Oxford University University of London [Read before the ROYAL STATISTICAL SOCIETY on Wednesday, January 19th, 1972, the President Professor G. A. BARNARD in the Chair] SUMMARY Asymptotically efficient rank invariant test procedures for detecting differences between two groups of independent observations are derived. These are generalized to test between two groups of independent censored observations, to test between many groups of observations, and to test between groups after allowance for the effects of concomitant variables.
    [Show full text]